When Discomfort Stops Being Temporary

The knee that hurts when walking down stairs. The shoulder that aches when lifting your arm. The hip that begins to limit you after walking or standing for prolonged periods.

Many musculoskeletal disorders start this way: gradually, intermittently, and seemingly harmlessly. When these warning signs are normalized and the condition progresses without an accurate diagnosis, pain can persist, physical function deteriorates, and the issue advances toward chronicity, making its clinical management far more complex.

Pain and inflammation are symptoms, not a diagnosis. Analgesics and anti-inflammatory medications can help control them, but reducing pain does not necessarily mean the root cause has been identified or treated.

When discomfort persists, recurs, or begins to interfere with your daily activities, it is time to seek a precise diagnosis. It is not merely about suppressing the pain, but understanding why it hurts, intervening in time, and restoring function.

What Type of Joint Pain Do You Have?

Not All Pain Is the Same: Understanding Its Origin Changes the Treatment

When pain persists, it is not enough to know where it hurts; it is equally essential to identify what mechanism is driving it. Currently, musculoskeletal pain can be classified into three primary mechanisms:

• Nociceptive Pain: Occurs when pain receptors are activated in tissues such as joints, tendons, muscles, ligaments, or bone. It is the predominant mechanism in many musculoskeletal injuries, degenerative processes, and inflammatory conditions.
• Neuropathic Pain: Caused by a lesion or disease affecting the somatosensory nervous system. It can present as burning sensations, electric shocks, tingling, numbness, or radiating pain.
• Nociplastic Pain: Arises from altered pain processing within the central nervous system, where symptoms cannot be fully explained by ongoing tissue damage or clear nerve lesions. It is particularly relevant in persistent or chronic pain syndromes.

These mechanisms can coexist. Consequently, two patients with the exact same structural imaging findings may experience completely different pain profiles and will not necessarily respond to the same therapeutic intervention.

Beyond the neurobiological mechanism, a comprehensive medical assessment analyzes where the pain originates: it may stem directly from the joint itself or from surrounding periarticular structures, including tendons, muscles, ligaments, or bursae.

Identifying where it hurts is important; understanding why it hurts is what allows for targeted, effective treatment.

Therapeutic Exercise: The Most Overlooked Joint Pain Treatment

Major clinical guidelines—such as the National Institute for Health and Care Excellence (NICE NG226) and the Colegio Americano de Reumatología junto con la Arthritis Foundation (ACR/AF) strongly endorse exercise as a fundamental pillar in managing degenerative joint disorders that cause pain, inflammation, and joint instability.
It requires a progressive, individualized program designed with specific therapeutic goals. Avoiding movement can further degrade functional capacity. Contrary to common belief, an arthritic or injured joint does not require complete unloading; it requires optimal mechanical loading tailored to its current capacity.

Treating the Joint Also Means Reducing Overload Factors

It is not solely about how much weight a joint bears, but how that mechanical load is distributed.

Gait abnormalities, muscular weakness, biomechanical imbalances, or improper footwear can alter force transmission through the lower kinetic chain. In many patients, these factors perpetuate or aggravate chronic symptoms.

For this reason, joint pain treatment should rarely focus exclusively on the painful site. A thorough biomechanical evaluation may include assessments of muscle strength, joint mobility, gait analysis, lower-extremity alignment, physical activity levels, footwear, and weight management.

In sports medicine, we do not aim merely to treat the symptom of pain: we seek to understand why it arose, what factors are sustaining it, and what biomechanical adjustments can help you move better.

Are Supplements Worth Taking?

It depends on the individual patient, the clinical diagnosis, and the specific compound. Certain supplements may offer modest symptomatic relief, but none serve as substitutes for the core interventions with the highest level of clinical evidence for osteoarthritis: therapeutic exercise, progressive strength training, patient education, physical activity, and weight management when indicated.

It is also vital to recognize that supplements can cause adverse effects or interact with prescription medications. This is particularly critical in individuals taking anticoagulants or antiplatelet therapies, or those with underlying gastrointestinal, hepatic, renal, or cardiovascular conditions.

Curcumin: To date, curcumin holds the strongest scientific backing for osteoarthritis symptoms. Multiple systematic reviews from 2020 to 2025 demonstrate that it can reduce pain and stiffness while improving functional scores, showing tolerability comparable to standard NSAIDs in select clinical trials.

Omega-3 Fatty Acids: Research shows they demonstrate greater clinical utility in systemic inflammatory arthritis rather than in mechanical osteoarthritis.

Anti-Inflammatories and Analgesics: The Goal Is Not Simply to “Numb the Pain”

Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) can be useful temporary tools, but they must be integrated into a comprehensive plan that accounts for each patient’s definitive diagnosis, muscle strength, mobility, exercise habits, body weight, athletic loading, and biomechanical factors.

While medications help manage flare-ups, their primary role is to alleviate acute symptoms to facilitate movement and rehabilitation; they do not reverse the underlying pathology of osteoarthritis or regenerate articular cartilage.

Prescribing medication requires careful consideration of pain intensity, the specific joint involved, dermatological sensitivities, patient age, and—most importantly—cardiovascular, gastrointestinal, renal, and hepatic medical histories. Therefore, their prescription and duration must be strictly directed by medical professionals.

Physical Therapy for Joint Pain: Restoring Movement, Strength, and Function

When a joint hurts, the instinctive human reaction is to immobilize it. However, excessive rest triggers muscle atrophy, joint stiffness, and diminished functional capacity, creating a debilitating cycle where pain leads to inactivity, and inactivity impairs tissue recovery.

The objective of high-quality rehabilitation is not merely to offer a few hours of temporary pain relief. Physical therapy aims to progressively rebuild lost physical capacities: range of motion, strength, joint stability, balance, neuromuscular coordination, and load tolerance.

Depending on individual clinical needs, a structured rehabilitation program may incorporate progressive resistance training, joint mobilization, aerobic conditioning, neuromuscular control drills, and task-specific exercises tailored to occupational or athletic demands.

Robust clinical evidence confirms that therapeutic exercise significantly improves pain scores, physical function, and overall quality of life in individuals with knee osteoarthritis.

Professional supervision ensures the program is built around the patient’s baseline capacity and diagnosis. It allows clinicians to fine-tune exercise selection, modify loading parameters, and progressively increase difficulty as tissue tolerance improves. Studies indicate that supervised exercise yields superior outcomes in pain reduction and functional recovery compared to unguided routines, largely due to proper technique execution, progression, and treatment adherence.

Shockwave Therapy: A Non-Invasive Tool for Persistent Musculoskeletal Pain

When pain in tendons or periarticular soft tissues persists despite initial conservative care, Extracorporeal Shockwave Therapy (ESWT) serves as an effective, non-invasive therapeutic modality for specific musculoskeletal conditions.

Unlike modalities designed solely for short-term symptomatic numbing, shockwaves deliver focused mechanical acoustic energy directly into damaged tissues. These impulses trigger beneficial biological cascades, including modulation of nociceptive pathways, regulation of local inflammation, and activation of mechanotransduction—the cellular process translating mechanical stimuli into biochemical repair signals.

Two primary technologies exist: Radial Shockwaves: Disperse energy more superficially and across wider areas, making them ideal for broad myofascial indications. Focused Shockwaves: Concentrate acoustic energy at deeper focal points, allowing precise targeting of deep entheses, bone-tendon junctions, and deeper soft-tissue pathologies.

Selecting between radial and focused modalities depends entirely on the anatomical structure, depth of the lesion, diagnostic findings, and specific therapeutic goals.

Interventional Joint Injections: What They Are and What to Realistically Expect

Joint injections (infiltrations) are minimally invasive outpatient procedures that deliver therapeutic agents directly into an affected joint cavity or surrounding soft-tissue structure. When properly indicated they represent a powerful clinical tool to relieve pain, stimulate local tissue repair, enhance joint stability, and facilitate active physical rehabilitation.

A primary clinical advantage is localized therapeutic delivery without systemic adverse effects. Furthermore, when performed under ultrasound guidance, the physician visualizes anatomical landmarks, articular recesses, tendons, and neurovascular bundles in real time, ensuring millimeter precision during needle navigation.

Depending on the clinical objective, various injectable therapies may be utilized, including corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), or cellular therapies. The selection must be individualized based on diagnosis, symptom duration, affected joint, severity of structural damage, and the patient’s overall health profile.

Biologic and Regenerative Therapies: New Tools in Joint Care

In recent years, biologic and orthobiologic therapies have expanded treatment possibilities for musculoskeletal injuries and degenerative joint diseases. Their goal extends beyond symptomatic pain relief: they aim to modulate the local intra-articular microenvironment and foster cellular conditions that support tissue repair and long-term functional recovery.

However, regenerative medicine must be approached with scientific realism. Currently, no injectable therapy can promise or guarantee the complete structural regrowth of lost articular cartilage. Clinical outcomes depend heavily on baseline disease severity, patient age and metabolic health, accurate anatomical placement, and the specific biologic preparation utilized.

Consequently, orthobiologics must be integrated into a comprehensive therapeutic strategy—not viewed as a miracle panacea or an automatic replacement for surgery when joint replacement or reconstruction is clearly indicated.

Platelet-Rich Plasma (PRP): One of the Most Studied Biologics

Platelet-Rich Plasma (PRP) is an autologous biologic derived from the patient’s own peripheral blood. Through centrifugation, platelets are concentrated alongside essential bioactive signaling molecules, cytokines, and growth factors that regulate cell recruitment, modulate local inflammation, and stimulate tissue repair pathways.

In mild-to-moderate knee osteoarthritis, extensive randomized controlled trials and meta-analyses show that ultrasound-guided PRP injections significantly reduce pain and improve joint function, with clinical benefits frequently sustained over 6 to 12 months.

While PRP represents one of the most thoroughly investigated intra-articular biologics, clinical efficacy can vary. Not all PRP formulations are identical: variations in platelet concentrations, leukocyte inclusion (leukocyte-rich vs. leukocyte-poor PRP), activation methods, and dosing protocols directly influence biological outcomes.

PRP should be clinically understood as a powerful tool to control intra-articular symptoms and restore joint function, rather than an intervention that predictably rebuilds lost hyaline cartilage.

Prolotherapy: Stimulating a Controlled Biological Response

Dextrose prolotherapy is an interventional regenerative technique involving the injection of hypertonic dextrose solutions into joint spaces, ligaments, or enthesopathies.

It has been extensively investigated for chronic musculoskeletal pain conditions, particularly knee osteoarthritis.

Experimental and clinical studies demonstrate several proposed therapeutic mechanisms:

• Activation of local cellular signaling and mechanotransduction pathways;
• Modulation of local chronic inflammatory states;
• Proliferation of fibroblasts and enhanced synthesis of extracellular matrix collagen;
• Upregulation of local growth factor expression;
• Neurolytic modulation of transient receptor potential vanilloid-1 (TRPV1) nociceptive fibers, directly reducing pain signaling.

In animal models, hypertonic dextrose exposure promotes fibroblast recruitment, increases collagen bundle diameter, and enhances the tensile strength of treated ligaments and tendons.

In clinical research, a classic randomized trial compared dextrose prolotherapy, saline injections, and home exercise routines. At 52 weeks, patients receiving dextrose prolotherapy exhibited significantly greater improvements in WOMAC pain and function scores compared to control groups.

Subsequent trials and systematic reviews continue to validate its therapeutic role in mild-to-moderate joint degeneration.

Mesenchymal Stem / Stromal Cells (MSCs): A Promising, Evolving Frontier

Therapies utilizing mesenchymal stromal cells (MSCs) represent one of the most dynamic frontiers in musculoskeletal regenerative research.

Modern scientific consensus indicates that their primary therapeutic mechanism is paracrine, immunomodulatory, and cellular signaling, rather than the oversimplified notion that injected cells engraft and directly transform into brand-new cartilage.

Recent clinical investigations in knee osteoarthritis show promising safety and functional outcomes, with clinical trials and systematic reviews demonstrating reductions in pain and improvements in functional mobility in the months following targeted administration.

The Goal Is Not to Avoid Surgery: It Is to Choose the Right Treatment

Modern musculoskeletal medicine should not create an artificial dichotomy between “conservative management” and “surgery.”

Therapeutic exercise, physical therapy, targeted pharmacotherapy, ultrasound-guided injections, orthobiologics, and surgery are simply different clinical tools designed for different pathologies and distinct stages of disease progression.

A sound medical strategy delivers the right intervention to the right patient at the right time.

Sometimes that means specialized rehabilitation; other times it involves an ultrasound-guided orthobiologic procedure; and when clear surgical indications exist, orthopedic surgery is an essential and appropriate pathway toward functional restoration.

Treatment Is a Ladder, Not a Leap

The therapeutic ladder for joint pain follows clear clinical logic: begin with the least invasive, evidence-based interventions and advance systematically according to individual response. Skipping rungs rarely expedites healing; more often, it complicates recovery. The non-negotiable starting point remains unchanged: identifying the root cause of the pathology.

If you have been living with persistent joint pain that fails to resolve, the issue is rarely a shortage of available treatments—it is that the underlying primary cause has not yet been accurately identified. A specialized diagnostic evaluation that addresses the root dysfunction, rather than masking surface symptoms, is the prerequisite for any joint treatment plan with real potential for success.

At Olympia, joint pain management begins with an exhaustive assessment integrating diagnostic musculoskeletal ultrasound and clinical physical examination to pinpoint the true cause of your condition. Our multidisciplinary medical team—incorporating sports medicine physicians, orthopedic specialists, and physical therapists—determines the exact level of intervention required before prescribing any therapy. At Olympia, our clinical protocol always starts with identifying the root cause before proposing any intervention.

You have been dealing with knee or lower back pain for months. You have tried anti-inflammatories, visited a physical therapist, and someone—your doctor or an acquaintance at the gym—mentioned prolotherapy. You search for information and find a bit of everything: promises of recovery without surgery, glowing testimonials, and voices dismissing it as a passing trend. The real question is whether behind these dextrose injections lies solid clinical evidence or simply a well-marketed placebo effect.

The answer, as is often the case in medicine, is not simple. In specialized sports medicine centers, prolotherapy is part of a broader therapeutic plan: it is not administered without first identifying the root cause of the problem through a thorough clinical history, physical examination, and diagnostic imaging. That difference—between routinely prescribing an injection versus integrating it into a structured protocol—determines who genuinely benefits and who wastes time and money.

In this article, you will learn what joint prolotherapy is and how it acts on damaged tissue, which injuries are backed by scientific evidence, what a standard protocol looks like, the associated risks, how it compares to PRP or corticosteroids, and when it makes sense to seek a specialized medical evaluation.

What Is Prolotherapy and How Does It Act on Damaged Tissue?

The Logic Behind Controlled Inflammatory Stimulation

Prolotherapy (or proliferative therapy) is based on a counterintuitive biological principle: to repair weakened tissue, you must first induce a controlled inflammatory response. Injecting an irritant solution into the target tissue triggers fibroblast proliferation and stimulates the synthesis of new collagen. The result is the progressive strengthening of ligaments, tendons, and joint capsules that have lost structural integrity due to wear and tear or an injury that never healed properly. That is where the name comes from: the goal is tissue regeneration, not merely anesthesia.

This mechanism explains why prolotherapy does not act like a corticosteroid. It does not suppress inflammation; it harnesses it as a repair tool. For this reason, pain may temporarily increase during the first 24 to 72 hours following a session before improving—this local reaction indicates that the healing cascade is underway.

What Is Injected and Where?

The most researched and widely utilized substance is hypertonic dextrose. Concentrations vary depending on the clinical indication and protocol: for intra-articular injections in knee osteoarthritis, most recent randomized clinical trials use 25% dextrose, which is the best

documented concentration for this indication; isolated studies have used up to 50%, although this does not represent the standard practice. For periarticular applications or at entheses, concentrations typically range between 12.5% and 15%. It is frequently combined with a local anesthetic to improve patient comfort, though its use varies by protocol and specialist preference.

Ultrasound guidance is highly recommended prior to and during any injection. Musculoskeletal ultrasound allows precise needle placement, real-time assessment of tissue quality, and ensures the solution is not delivered to a suboptimal location. Without ultrasound guidance, the procedure loses precision and safety.

Which Conditions Have Real Scientific Backing?

Knee Osteoarthritis: The Indication with the Strongest Evidence

In knee osteoarthritis, dextrose prolotherapy is supported by a 2016 systematic review and meta-analysis along with several subsequent randomized clinical trials, including those by Sit et al. (2020), Sert et al. (2019), and Teymouri et al. (2025). Results demonstrate pain reduction, functional improvement, and enhanced quality of life measured by scales such as the WOMAC index, showing clinically relevant effect sizes across most reviews. Nonetheless, authors note methodological heterogeneity and variable study quality, meaning the certainty of evidence is considered moderate and higher-rigor trials are still warranted before definitive clinical guidelines are established.

What remains clear is that in mild-to-moderate osteoarthritis unresponsive to conservative measures, prolotherapy is an option backed by real science. It is neither an unproven experimental gimmick nor a definitive cure-all while clinical research continues to mature.

Tendinopathies, Enthesopathies, and Chronic Low Back Pain

In chronic tendinopathies such as lateral epicondylalgia (tennis elbow), plantar fasciitis, or Achilles tendinopathy, clinical evidence is favorable, though heterogeneous. Standard protocols involve 3 to 6 sessions spaced 3 to 6 weeks apart, yielding positive outcomes in pain and function across most available literature. While unanimous consensus is absent, there is no scientific basis to dismiss its utility for these conditions.

The case for chronic low back pain is different and requires transparency: the trial by Maniquis-Smigel et al. (2017), which compared 5% dextrose against saline solution, found no statistically significant difference between groups. A Cochrane review concluded that prolotherapy is ineffective as a standalone treatment for chronic low back pain, though it may hold value as an adjunct to therapeutic exercise or spinal manipulation. Any claim that prolotherapy alone will cure chronic back pain is simply unsupported by current scientific literature.

What Does a Standard Treatment Protocol Look Like?

Sessions, Concentrations, and Frequency

In knee osteoarthritis, standard protocols utilize 25% dextrose via intra-articular or periarticular injections across monthly sessions for a minimum of 3 cycles. Some protocols extend up to 6 sessions depending on condition severity and individual clinical response. The 3- to 4-week interval between sessions is biologically driven: tissue requires sufficient time to process the regenerative stimulus before receiving another dose, based on published clinical protocols in reference trials.

For tendinopathies such as Achilles tendinopathy or lateral epicondylalgia, the standard approach involves 3 to 4 initial sessions, similarly spaced several weeks apart. The exact number of sessions is never rigid; it depends on clinical progression, lesion severity, and the overseeing specialist’s clinical judgment. Any protocol guaranteeing outcomes within a predetermined number of sessions without evaluating your medical history warrants caution.

What Happens During and After Each Session?

The procedure takes approximately 15 to 30 minutes, depending on the technique and number of target sites. Mild, manageable local discomfort occurs during the injection, which is minimized by the local anesthetic combined with the dextrose. Over the following 24 to 72 hours, experiencing increased local soreness and mild swelling is standard; this is not a complication, but rather an expected part of the therapeutic mechanism.

During this inflammatory phase, clinical protocols often advise limiting the use of nonsteroidal anti-inflammatory drugs (NSAIDs), as they can blunt the intended repair cascade; consult your specialist regarding specific post-procedure guidelines. Normal daily activities can generally be resumed within a few days, following relative rest guidelines tailored to the treated joint.

Side Effects, Risks, and Contraindications

Common Occurrences vs. Rare Complications

The most frequent adverse effects are local pain and temporary swelling (expected and transient), mild fatigue, and minor headaches. These symptoms reflect the physiological response to treatment and subside within a few days. Severe complications—such as localized infection, septic arthritis, or nerve injury—are exceptionally rare but documented in clinical literature.

An important consideration: underreporting of adverse events in clinical trials is a known limitation in this field. Existing studies likely underestimate the true frequency of minor reactions, making precise percentages difficult to establish. This does not mean prolotherapy is unsafe; rather, it underscores why it must always be conducted within a supervised medical setting.

When Is Prolotherapy Contraindicated?

Prolotherapy should not be performed under the following conditions:

• Active local skin/soft-tissue infection at the injection site, cellulitis, or abscess
• Systemic infection or septic arthritis
• Acute gouty arthritis or similar acute inflammatory flare-ups
• Uncontrolled coagulopathy or non-medically managed anticoagulation therapy
• Known allergy to any component of the injectable solution

Immunosuppression and diabetes are not absolute contraindications, but they require individualized clinical assessment prior to treatment. None of these conditions can be properly evaluated without a formal prior medical consultation.

Prolotherapy vs. PRP, Corticosteroids, and Physical Therapy

Which lasts longer and which acts faster

Corticosteroids offer the fastest relief: they significantly reduce pain in just a few days. However, their effectiveness diminishes in the medium term, and repeated use has negative effects on joint tissue. They are useful in specific situations, such as an upcoming competition or an acute pain crisis, but they are not a regenerative solution.

PRP shows more consistent results in degenerative lesions, with sustained improvement for up to 12 months in some studies. In knee osteoarthritis, the available evidence tends to favor PRP over dextrose prolotherapy in terms of pain and function, although the difference between the two options is not as significant as sometimes claimed, and individual patient profiles can tip the scales one way or the other. Prolotherapy occupies a specific place: it is a valid regenerative alternative when PRP is unavailable, when there are financial limitations, or when the primary goal is to consolidate long-term joint stability.

When to Choose Each Option

Physical therapy remains the cornerstone of musculoskeletal treatment. Prolotherapy is considered an adjunctive or alternative option when conservative therapy has failed after several months, rather than a primary first-line intervention. If immediate short-term relief is the priority, corticosteroids make sense in the acute phase. If the diagnosis points to ligamentous laxity, chronic enthesopathy, or mild-to-moderate osteoarthritis, prolotherapy or PRP represent more appropriate strategies for durable long-term outcomes. The final decision hinges on an accurate diagnosis, patient profile, and individual recovery goals.

When to See a Specialist and How to Know If You Are a Candidate

Signs You May Benefit

The patient profile most likely to benefit from prolotherapy is specific: chronic joint or tendon pain persisting for more than 3 to 6 months that has failed to improve with physical therapy or anti-inflammatories, without contraindications for interventional procedures, and with a confirmed diagnosis of ligament laxity, enthesopathy, or mild-to-moderate osteoarthritis. The ideal candidate has undergone a complete diagnostic evaluation that rules out active systemic inflammatory conditions or immediate surgical indications. If you have been living with unresolved pain and lack an accurate diagnosis, establishing that diagnosis is the essential first step before considering any injection.

What a Comprehensive Medical Evaluation Must Include

A thorough pre-treatment assessment includes a detailed clinical history, physical examination, diagnostic imaging (musculoskeletal ultrasound or MRI where clinically indicated), and, when necessary, laboratory work to rule out contraindications. At Olympia, Comprehensive Sports Medicine, this multidisciplinary approach is standard protocol: prolotherapy is never prescribed as a blanket first response, but as part of an integrated management plan that incorporates physical rehabilitation, sports nutrition, and continuous clinical follow-up. The objective is to treat the root cause of dysfunction, rather than performing repetitive injections without clinical rationale.

If you have been dealing with persistent joint pain and prolotherapy has been recommended to you, the next step is an evaluation with a sports medicine specialist to confirm candidacy, determine the appropriate protocol, and outline your complete path to recovery. Always consult a qualified specialist before making any treatment decisions.

Key Takeaways

Joint prolotherapy has demonstrated clinical efficacy in knee osteoarthritis and select chronic tendinopathies. It is neither an unscientific fad nor a universal cure-all. Treatment outcomes depend heavily on accurate diagnosis, solution concentration, protocol adherence, and patient candidacy. For chronic low back pain as a standalone monotherapy, current evidence does not support its isolated use.

Compared to PRP, corticosteroids, or physical therapy, prolotherapy occupies a distinct place within the therapeutic spectrum: it is neither universally superior nor inferior, but context-dependent. An image-guided injection performed within a comprehensive treatment plan holds far greater clinical value than an unguided procedure done without diagnostic rigor.

Before deciding whether prolotherapy is right for you, an evaluation by a specialist is necessary to assess the root cause of your pain—not just mask the symptom. At Olympia, Comprehensive Sports Medicine, that is where every recovery begins.